Low-Level Laser Therapy and Injectable Platelet-Rich Fibrin for Thin Gingival Phenotype.
- Conditions
- Periodontal Diseases
- Interventions
- Other: injecable platelet rich fibrin, and low level laser therapy radiation.
- Registration Number
- NCT06756854
- Lead Sponsor
- Faculty of Dental Medicine for Girls
- Brief Summary
Management of thin gingival phenotype using non-surgical methods (injection of liquid platelet rich fibrin and exposure to low level laser therapy
- Detailed Description
Thin gingival phenotype can lead to recession and root exposure. Liquid prf can be obtained by centrifugion of blood sample on speed 700 rpm for 3 min, then injection of this liquid in the attached gingiva and muco-gingival junction (3 times with 7 days interval) for the first group. The second group will be injected with I-PRF in the same method in addition to exposure to Low Level Laser therapy (after each injection of I-PRF). This method is expected to increase the thickness of the gingiva.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 7
- free systimatically good oral hygiene gingival thickness less than 1mm
- pregnancy or lactation pereiodontitis periodontal surgery orthodontic ttt tooth mobility,bruxism,crowding,missing or supernumerary teeth smoking
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Test group: injectable platelet rich fibrin+ low level laser therapy injecable platelet rich fibrin, and low level laser therapy radiation. patients with thin gingival phenotype (gingival thickness less than 1mm) recieve I-PRF+LLLT radiation just after the injection for 3 sessions with 7 days interval between the sessions.
- Primary Outcome Measures
Name Time Method Gingival thickness improvement in millimeters. 6 months after treatment clinical parameter
Keratinized tissue width improvement in millimeters. 6 months after treatment Clinincal parameter.
- Secondary Outcome Measures
Name Time Method Improvement of gingival index. 6 months after treatment Clinical parameter.
Improvement of bleeding on probing. 6 months after treatment Clinical parameter.
Improvement of sulcus depth. 6 months after treatment Clinical parameter.
Trial Locations
- Locations (1)
Alaa Elsayed
🇪🇬Cairo, Egypt